We are live on ! Find out more
ABPI

Accentia Biopharmaceuticals
ABPI

Delisted

ABPI was delisted on the 3rd of November, 2008.

Back to rankings

3 hedge funds and large institutions have $0 invested in Accentia Biopharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

100% less capital invested

Capital invested by funds: $25 → $0 (-$25)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ABPI Hedge Fund Activity: Q4 2014 in Review

3 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Accentia Biopharmaceuticals (ABPI) for Q4 2014, worth a combined $0 — down 100% from $25 a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ABPI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 3 institutional investors held Accentia Biopharmaceuticals (ABPI) as of Q4 2014, up from 2 in Q3 2014.
  • Funds reported $0 of Accentia Biopharmaceuticals stock for Q4 2014, down 100% quarter-over-quarter.
  • 1 fund opened new Accentia Biopharmaceuticals positions in Q4 2014 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q4 2014.